{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:45:53Z","timestamp":1790063153403,"version":"4.0.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cellular immune responses are of pivotal importance to understand SARS-CoV-2 pathogenicity. Using an enzyme-linked immunosorbent spot (ELISpot) interferon-\u03b3 release assay with wild-type spike, membrane and nucleocapsid peptide pools, we longitudinally characterized functional SARS-CoV-2 specific T-cell responses in a cohort of patients with mild, moderate and severe COVID-19. All patients were included before emergence of the Omicron (B.1.1.529) variant. Our most important finding was an impaired development of early IFN-\u03b3-secreting virus-specific T-cells in severe patients compared to patients with moderate disease, indicating that absence of virus-specific cellular responses in the acute phase may act as a prognostic factor for severe disease. Remarkably, in addition to reactivity against the spike protein, a substantial proportion of the SARS-CoV-2 specific T-cell response was directed against the conserved membrane protein. This may be relevant for diagnostics and vaccine design, especially considering new variants with heavily mutated spike proteins. Our data further strengthen the hypothesis that dysregulated adaptive immunity plays a central role in COVID-19 immunopathogenesis.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1046639","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T05:51:21Z","timestamp":1681710681000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19"],"prefix":"10.3389","volume":"14","author":[{"given":"Lidewij W.","family":"R\u00fcmke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter L.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailko","family":"Bossink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijs J. M.","family":"Limonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danya","family":"Muilwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenneke E. M.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Reusken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"van der Wal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing J.","family":"Thio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne M. G.","family":"van Os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Gremmels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Beekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Nijhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie M. J.","family":"Wensing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Heron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven F. T.","family":"Thijsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"B1","unstructured":"GenevaWorld Health Organization2020"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00364","article-title":"Immune parameters and COVID-19 infection \u2013 associations with clinical severity and disease prognosis","volume":"10","author":"Jesenak","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/S41586-020-2588-Y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/oxfimm\/iqaa007","article-title":"T Cell phenotypes in COVID-19 - a living review","volume":"2","author":"Hanna","year":"2021","journal-title":"Oxford Open Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cti2.1217","article-title":"Severe SARS-CoV-2 patients develop a higher specific T-cell response","volume":"9","author":"Demaret","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.592629","article-title":"Dynamics of CD4 T-cell and antibody responses in COVID-19 patients with different disease severity","volume":"7","author":"Koblischke","year":"2020","journal-title":"Front Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jinf.2020.08.036","article-title":"COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity","volume":"82","author":"Kroemer","year":"2020","journal-title":"J Infect"},{"key":"B8","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","article-title":"Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity","volume":"183","author":"Rydyznski Moderbacher","year":"2020","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0245532","article-title":"T Cell response to SARS-cov-2 infection in humans: A systematic review","volume":"16","author":"Shrotri","year":"2021","journal-title":"PloS One"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early induction of functional SARS-CoV-2-specific T-cells associates with rapid viral clearance and mild disease in COVID-19 patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms23137155","article-title":"Early and polyantigenic CD4 T-cell responses correlate with mild disease in acute COVID-19 donors","volume":"23","author":"Tarke","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B12","unstructured":"National institute for public health and the environment (RIVM)2022"},{"key":"B13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/J.JINF.2020.06.015","article-title":"Elevated nucleoprotein-induced interferon-\u03b3 release in COVID-19 patients detected in a SARS-CoV-2 enzyme-linked immunosorbent spot assay","volume":"81","author":"Thijsen","year":"2020","journal-title":"J Infect"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-325-7_18","article-title":"IL-7 addition increases spot size and number as measured by T-SPOT.TB (\u00ae)","volume":"792","author":"Feske","year":"2012","journal-title":"Methods Mol Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/FEMSPD\/FTAC035","article-title":"Differential vaccine-induced kinetics of humoral and cellular immune responses in SARS-CoV-2 naive and convalescent health care workers","volume":"80","author":"Smit","year":"2022","journal-title":"Pathog Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"16742","DOI":"10.1038\/s41598-020-73883-7","article-title":"Negative binomial mixed models for analyzing longitudinal CD4 count data","volume":"10","author":"Yirga","year":"2020","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-06509-6","article-title":"Severity-associated markers and assessment model for predicting the severity of COVID-19: a retrospective study in hangzhou, China","volume":"21","author":"Qi","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.18.159202","article-title":"Divergent SARS-CoV-2-specific T and b cell responses in severe but not mild COVID-19","volume":"50","author":"Oja","year":"2020","journal-title":"Eur J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.596684","article-title":"Dynamic SARS-CoV-2-Specific immunity in critically ill patients with hypertension","volume":"11","author":"Zeng","year":"2020","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.684014","article-title":"Potent SARS-CoV-2-Specific T-cell immunity and low anaphylatoxin levels correlate with mild disease progression in COVID-19 patients","volume":"12","author":"Lafon","year":"2021","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109414","article-title":"Distinctive features of SARS-CoV-2-specific T-cells predict recovery from severe COVID-19","volume":"36","author":"Neidleman","year":"2021","journal-title":"Cell Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.603563","article-title":"Impaired cellular immunity to SARS-CoV-2 in severe COVID-19 patients","volume":"12","author":"Ni","year":"2021","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e20202617","DOI":"10.1084\/JEM.20202617","article-title":"Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection","volume":"218","author":"Le Bert","year":"2021","journal-title":"J Exp Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0782-6","article-title":"Broad and strong memory CD4+ and CD8+ T-cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19","volume":"21","author":"Peng","year":"2020","journal-title":"Nat Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e142167","DOI":"10.1172\/jci.insight.142167","article-title":"High levels of SARS-CoV-2\u2013specific T-cells with restricted functionality in severe courses of COVID-19","volume":"5","author":"Schub","year":"2020","journal-title":"JCI Insight"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T-cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-00919-x","article-title":"ACE2-independent infection of T lymphocytes by SARS-CoV-2","volume":"71","author":"Shen","year":"2022","journal-title":"Signal Transduction Targeting Ther"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2020.00827","article-title":"Reduction and functional exhaustion of T-cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.immuni.2020.07.026","article-title":"Acute SARS-CoV-2 infection impairs dendritic cell and T-cell responses","volume":"53","author":"Zhou","year":"2020","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e150613","DOI":"10.1172\/JCI150613","article-title":"Seasonal coronavirus-specific b cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19","volume":"131","author":"Aguilar-Bretones","year":"2021","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.839367","article-title":"Heterologous immune responses of serum IgG and secretory IgA against the spike protein of endemic coronaviruses during severe COVID-19","volume":"13","author":"Smit","year":"2022","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.cell.2020.12.015","article-title":"COVID-19-neutralizing antibodies predict disease severity and survival","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/SCIENCE.ABD4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/SCIIMMUNOL.ABE8063","article-title":"The known unknowns of T-cell immunity to COVID-19","volume":"5","author":"Karlsson","year":"2020","journal-title":"Sci Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140965","article-title":"SARS-CoV-2-specific T-cell responses and correlations with COVID-19 patient predisposition","volume":"130","author":"Sattler","year":"2020","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100092","article-title":"Robust T-cell response toward spike, membrane, and nucleocapsid SARS-CoV-2 proteins is not associated with recovery in critical COVID-19 patients","volume":"1","author":"Thieme","year":"2020","journal-title":"Cell Rep Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.637651","article-title":"The case for S2: The potential benefits of the S2 subunit of the SARS-CoV-2 spike protein as an immunogen in fighting the COVID-19 pandemic","volume":"12","author":"Shah","year":"2021","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.02.038","article-title":"Cryopreservation-related loss of antigen-specific IFN\u03b3 producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy","volume":"35","author":"Ford","year":"2017","journal-title":"Vaccine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1046639\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T08:50:20Z","timestamp":1682326220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1046639\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2023.1046639"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1046639","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"article-number":"1046639"}}